Dose recommendations for anticancer drugs in patients with renal or hepatic impairment: an update

Lancet Oncol. 2023 Jun;24(6):e229. doi: 10.1016/S1470-2045(23)00216-4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Area Under Curve
  • Humans
  • Kidney
  • Renal Insufficiency* / metabolism

Substances

  • Antineoplastic Agents